February 17, 2012

One of the main plotlines of the big story called the drug industry over the past several years has been the patent cliff, the steady loss of patent protection on blockbuster primary care drugs and subsequent generic competition that has forced many drug companies to find new revenue streams.

November 9, 2011

Generic drug maker Mylan has bought rights to a drug delivery platform made by Pfizer that will allow it to make generic versions of two GlaxoSmithKline respiratory drugs, Mylan said Wednesday.

October 10, 2011

The Food and Drug Administration has approved a new product for chronic obstructive pulmonary disease made by Boehringer Ingelheim Pharmaceuticals, the drug maker said.

September 22, 2011

Epinephrine inhalers will not be made or sold after Dec. 31, and patients using them should get new prescriptions to replace them, the Food and Drug Administration said Thursday.

April 19, 2011

InhalerWear on Tuesday announced its launch of a neoprene cover for inhalers that will help make carrying around an inhaler “trendy and cool” to children and teenagers. The new inhaler can be clipped to a backpack, purse or belt loop.

March 16, 2011

The Food and Drug Administration on Wednesday announced that the only over-the-counter asthma inhaler sold in the United States no longer will be available as of Dec. 31 as part of an international agreement to stop the use of substances that damage the environment.

March 8, 2011

HealthOneMed has launched a device that combines the abilities of pillboxes, reminders, dispensers and medication alerts into one.

December 17, 2010

A link may exist between diabetes and the use of inhaled corticosteroids to treat asthma and chronic obstructive pulmonary disease, according to published reports.

July 18, 2010

Some stolen inhalers for patients with asthma and chronic obstructive pulmonary disease have turned up...

June 21, 2010

Generex Biotechnology Corp. will be among the companies exhibiting at an upcoming American Diabetes Association...

June 2, 2010

Sandoz has acquired privately owned U.S. drug maker Oriel Therapeutics, the generics arm of Novartis...

April 12, 2010

The Food and Drug Administration will start phasing out asthma and chronic obstructive pulmonary disease...

January 13, 2010

Data from a recent review of a treatment for chronic obstructive pulmonary disease do not...

January 10, 2010

Sepracor received a two-year extension on its patent for an insomnia drug, the drug maker...

August 12, 2007

The global respiratory drug market is projected to exceed sales of $44 billion by 2010,...